Heinz Ventures Fund I eyes medtech targets, adds venture partners

Published on January 6, 2025

Seed-stage risks and opportunities may be contributing to diminished quality of medtech and biopharma investment opportunities for later-

Continue reading on website
Other news

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

January 6, 2025
including working capital, research and development expenses, repayment or redemption of existing indebtedness and capital expenditures.

Community Coin Reveals Impactful Project Empowering Individuals to Give Back and Drive Real Change

January 6, 2025
support real-world local projects or fund charitable initiatives globally with every transaction, investment, or action within the Community